🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this intervention study is to learn if giving children influenz...
Status
Recruiting
Location
University of Turku
Start Date
2025-10-27
Trial ID
NCT07310472
Treatments Being Tested
To evaluate the bacterial-viral interactions between LPS and Fluenz as a mo...
Status
Completed
Location
Multiple Locations
Start Date
2015-12
Trial ID
NCT02642237
Allergic rhinitis (AR) is a condition that exists when an individual with a...
Status
Completed
Location
US EPA Human Studies Facility
Start Date
2008-01
Trial ID
NCT00617110
Treatments Being Tested
Egg allergy is common in early childhood, affecting at least one in 50 pres...
Status
Completed
Location
Ulster Hospital
Start Date
2014-09
Trial ID
NCT02111512
Treatments Being Tested
This study will serve to determine how influenza infection alters the bacte...
Status
Completed
Location
UCLA
Start Date
2011-02
Trial ID
NCT02597647
In recent years, influenza viruses that have traditionally infected animals...
Status
Completed
Location
University of Rochester Medical Center
Start Date
2010-09
Trial ID
NCT01175122
Treatments Being Tested
This study will investigate the effects of woodsmoke (WS) exposure on human...
Status
Recruiting
Location
Mary Ellen Jones
Start Date
2025-09-26
Trial ID
NCT06841913
This is a prospective randomized, open label clinical trial in approximatel...
Status
Completed
Location
Duke University Medical Center
Start Date
2018-10-15
Trial ID
NCT03600428
Treatments Being Tested
The purpose of this research is to compare the safety and ability to stimul...
Status
Completed
Location
Saint Louis University
Start Date
2005-09
Trial ID
NCT00231907
To investigate the safety and immunogenicity profile of of a novel nasal sp...
Status
Unknown
Location
HKU Phase 1 Clinical Trials Centre
Start Date
2021-03-29
Trial ID
NCT04809389
Treatments Being Tested